ClinicalTrials.gg
SuspendedNCT05484219FUNUpdated May 16, 2025

Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations

An interventional study of Functional navigation in Tumor, Brain, Arteriovenous Malformations and Cavernoma, sponsored by Sklifosovsky Institute of Emergency Care. Suspended at 1 site in Russian Federation. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2025-05-16.

Sponsored by Sklifosovsky Institute of Emergency Care · Not applicable, Interventional, and Treatment

Why this study was suspended
technical issues
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 79 Years
Sex
All
01

Study summary

The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery.

Read the detailed description

Functional images (functional magnetic resonance imaging (fMRI), transcranial magnetic stimulation (TMS), tractography) loaded in neuronavigation are called functional navigation. It is usually combined with anatomical data and allows to display eloquent brain areas. Currently there are plenty of studies concerning possibilities of it's use. In our research we plan to confirm this data and to supplement them with calculating a safe distance from motor areas to various mass lesions in preoperative scans where neurological deficits is not likely to appear after surgery. In case of success this data can be a foundation for further researches specifying indications for use of intraoperative neuromonitoring and possibility of it's replacement with functional navigation in some cases.

The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery. For each patient a surgeon intraoperatively will assess locations of motor cortex and corticospinal tract found with direct cortical and subcortical stimulation and capture them. After surgery he will compare this data with functional preoperative scans and virtual motor centers constructed based on tractography. Influence of various factors on precision of functional navigation will be studied and safe distance between motor brain areas and mass lesion borders will be calculated.

02

Conditions studied

  • Tumor, Brain
  • Arteriovenous Malformations
  • Cavernoma

Keywords

  • brain tumor
  • arteriovenous malformation
  • cavernoma
  • cavernous malformation
  • functional navigation
03

In context

Brain Neoplasms

2,440 studies on the registry are indexed under Brain Neoplasms; 540 are open to participants now.

This study's planned enrollment of 50 is above the median of 40 across 1,831 interventional studies indexed under Brain Neoplasms.

Browse Brain Neoplasms studies →

Lead sponsor

Sklifosovsky Institute of Emergency Care is the lead sponsor of 13 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all intracranial tumors
  • arteriovenous malformations
  • cavernous malformations
  • supratentorial localization
  • newly diagnosed
  • age 18-79 years
  • unaltered consciousness
  • error of patient registration in neuronavigation no more than 2 mm
  • possibility to perform "positive mapping" strategy

Exclusion criteria

Exclusion Criteria:

  • to magnetic resonance imaging or transcranial magnetic stimulation
  • inability to build tractography in neuronavigation
  • predicting of intraoperative brain shift 6 mm and more without possibility to correct it
  • real intraoperative brain shift 6 mm and more without possibility to correct it
  • previously performed brain radiotherapy
  • pregnancy
  • breast feeding
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Surgery

    Image-guided resection of brain tumors and vascular malformations

    Device: Functional navigation

Interventions

  • DeviceFunctional navigation

    Surgeon removes brain tumor or vascular malformation and assesses location of motor areas with functional navigation and intraoperative neuromonitoring

06

What researchers measure

Primary outcomes

  1. Accuracy of functional navigation (in millimeters)

    Maximal distance from the most remote margin of cortical hand/leg motor area or corticospinal tract in the area of corona radiata in functional navigation to the nearest margin of this area/tract in direct cortical/subcortical stimulation

    Time frame: Intraoperatively

  2. Accuracy of location of cortical hand/leg motor area, built according to tractography (in millimeters)

    Maximal distance from the most remote margin of cortical hand/leg motor area, built according to tractography and loaded into navigation, to the nearest margin of this area in direct cortical stimulation

    Time frame: Intraoperatively

Secondary outcomes

  1. Constancy of location of cortical hand/leg motor area in fMRI/TMS in relation to precentral gyrus (in millimeters)

    Maximal distance from the most remote margin of cortical hand/leg motor area in fMRI/TMS to the nearest margin of precentral gyrus

    Time frame: Within 2 days before surgery

  2. Factors, violating precision of fMRI/TMS/tractography

    Which factors lead to disappearing, thinning and dislocation of cortical hand/leg motor areas and corticospinal tract in fMRI/TMS/tractography

    Time frame: Within 2 days before surgery

  3. Motor function (in grades)

    Motor function is assessed in Medical Research Council scale

    Time frame: Within 10 days after surgery

  4. Distance to stop resection border (in millimeters)

    Minimal distance from the nearest margin of cortical hand/leg motor area or corticospinal tract to the nearest border of resection of tumor/vascular malformation

    Time frame: Intraoperatively

  5. Safe resection distance in functional navigation (in millimeters)

    This outcome is only measured in patients with no deterioration of motor function after surgery. Safe resection distance = accuracy of functional navigation + distance to stop resection border

    Time frame: Within 10 days after surgery

  6. Duration of direct cortical and subcortical mapping (in minutes)

    How long did it take to perform direct cortical and subcortical mapping

    Time frame: Intraoperatively

  7. Extent of resection (in percents)

    Extent of resection = (preoperative tumor volume - postoperative tumor volume) / preoperative tumor volume x 100

    Time frame: Within 48 hours after surgery

  8. Karnofsky performance status (in percents)

    Assessment of patients' possibilities to self-service in Karnofsky Performance Status scale

    Time frame: Within 10 days after surgery

  9. Cerebral complications

    Which cerebral complications arose after surgery

    Time frame: From admission to intensive care unit after surgery till hospital discharge, up to 365 days

07

Study locations

1 site
  • Sklifosovsky Institute of Emergency Care
    Moscow, 129090, Russian Federation
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05484219
Lead sponsor
Sklifosovsky Institute of Emergency Care
Responsible party
Alexander Dmitriev (Principal Investigator, Sklifosovsky Institute of Emergency Care) — Principal investigator
First posted
Aug 2, 2022
Start date
Sep 1, 2022
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
May 16, 2025

Study contacts

Alexander Dmitriev, MD
principal investigator · Sklifosovsky Institute of Emergency Care

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion